Castleview Partners’s Alkermes ALKS Stock Holding History

Castleview Partners’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,214	Closed	-$38K	–	677
2023 Q2	$38K	Buy	+1,214	New	+$36.8K	0.03%	294

Other funds holding ALKS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Castleview Partners's ALKS Position: Q3 2023 in Review

Castleview Partners sold out of Alkermes (ALKS) in Q3 2023, closing a stake of 1,214 shares — an estimated $38K sold.

Castleview Partners first reported a position in ALKS in Q2 2023 and held it in 1 quarter. The position peaked at $38K in Q2 2023. 306 funds tracked by Wall St. Rank hold ALKS as of Q3 2023.

Castleview Partners reported no remaining Alkermes position as of Q3 2023 after selling out during the quarter.
Castleview Partners sold 1,214 Alkermes shares in Q3 2023, an estimated $38K.
Castleview Partners first reported a position in Alkermes in Q2 2023 and held it in 1 quarter.
Castleview Partners's Alkermes position peaked at $38K in Q2 2023.
306 funds tracked by Wall St. Rank held Alkermes as of Q3 2023.

Based on Castleview Partners's 13F filing for Q3 2023, filed 26 Oct 2023.